Natus shareholders received $33.50 in cash for each share of company common stock.
The companies will deploy multiple AI-powered software solutions to identify hidden cardiovascular conditions.
The test will help diagnose diseases, such as multiple sclerosis, Alzheimer’s and Parkinson’s, as well as brain injuries.
Medtronic will immediately begin co-promotion of CathWorks’ FFRangio System in the US, Europe and Japan.
Use of the EMAS algorithm will enable healthcare professionals to identify valvular heart disease in patients.
Give your business an edge with our leading industry insights.
The new simulator is developed by medical simulation training company VirtaMed.
The molecular SARS-CoV-2 test relies on the RHINOstic Automated Nasal Swab from Rhinostics.
The company’s fourth quarter worldwide revenue declined by 1% on a reported basis to $8.09bn.
The Sleepio app leverages an AI algorithm to offer customised digital cognitive behavioural therapy for insomnia (CBT-I).
Mainz will leverage Dante’s various established commercial channels to introduce ColoAlert in Italy and the UAE.